Neuromodulation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuromodulation stocks.

Neuromodulation Stocks Recent News

Date Stock Title
May 16 BSX HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition
May 16 BSX NICE recommends targeted radiation therapy for liver tumours
May 16 NRXS NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
May 16 BSX Boston Scientific on the importance of positive company culture at Cork facility
May 16 RSLS Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 15 NURO NeuroMetrix GAAP EPS of -$1.67
May 15 RSLS ReShape Lifesciences reports Q1 results
May 15 NRXS NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
May 15 RSLS ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
May 15 NURO NeuroMetrix Reports Q1 2024 Business Highlights
May 15 ITGR Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects
May 15 BSX Centene (CNC) to Continue Serving Kansas' Medicaid Members
May 15 BSX Boston Scientific recalls more than 1M angiographic catheters
May 15 BSX Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
May 15 BSX GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy
May 15 BSX 3 Solid Buys From MedTech Following 2024 Guidance Raise
May 15 BSX Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year?
May 15 BSX Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
May 15 NMTC NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
May 14 NMTC NeuroOne Medical Technologies GAAP EPS of -$0.11
Neuromodulation

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to synaptic transmission in which an axonal terminal secretes neurotransmitters to target fast-acting receptors of only one particular partner neuron. Neuromodulators are neurotransmitters that diffuse through neural tissue to affect slow-acting receptors of many neurons. Major neuromodulators in the central nervous system include dopamine, serotonin, acetylcholine, histamine, and norepinephrine. Neuromodulators are known to have modulatory effects on target areas such as decorrelation of spiking, increase of firing rate, sharpening of spatial tuning curves, maintenance of increased spiking during working memory.A neuromodulator can be conceptualized as a neurotransmitter that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. Such neuromodulators end up spending a significant amount of time in the cerebrospinal fluid (CSF), influencing (or "modulating") the activity of several other neurons in the brain. For this reason, some neurotransmitters are also considered to be neuromodulators, such as serotonin and acetylcholine.Neuromodulation is often contrasted with classical fast synaptic transmission. In both cases the transmitter acts on local postsynaptic receptors, but in neuromodulation, the receptors are typically G-protein coupled receptors while in classical chemical neurotransmission, they are ligand-gated ion channels. Neurotransmission that involves metabotropic receptors (like G-protein linked receptors) often also involves voltage-gated ion channels, and is relatively slow. Conversely, neurotransmission that involves exclusively ligand-gated ion channels is much faster.
A related distinction is also sometimes drawn between modulator and driver synaptic inputs to a neuron, but here the emphasis is on modulating ongoing neuronal spiking versus causing that spiking.

Browse All Tags